Last update 08 May 2025

Bacterial top IV x Bacterial DNA gyrase x GR

Basic Info

Related Targets
Bacterial top IVBacterial DNA gyraseGR

Related

6
Drugs associated with Bacterial top IV x Bacterial DNA gyrase x GR
Ciprofloxacin Hydrochloride/Fluocinolone Acetonide
Target
Bacterial DNA gyrase x Bacterial top IV x GR
Mechanism
Bacterial DNA gyrase inhibitors [+2]
Active Org.
Editorial Salvat SLEditorial Salvat SL [+3]
Originator Org.
Laboratorios Salvat SALaboratorios Salvat SA
Active Indication
Acute otitis externa [+3]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Ukraine
First Approval Date20 Feb 2010
Ciprofloxacin/Dexamethasone
Target
Bacterial DNA gyrase x Bacterial top IV x GR
Mechanism
Bacterial DNA gyrase inhibitors [+2]
Active Org.
Sandoz, Inc.
Originator Org.
Novartis Pharma AG
Active Indication
Acute otitis media [+1]
Inactive Indication
Eye Diseases
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date18 Jul 2003
Ciprofloxacin Hydrochloride/Hydrocortisone
Target
Bacterial DNA gyrase x Bacterial top IV x GR
Mechanism
Bacterial DNA gyrase inhibitors [+2]
Active Org.
Sandoz, Inc. [+1]
Originator Org.
Novartis Pharma AG
Active Indication
Acute otitis externa [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date10 Feb 1998
24
Clinical Trials associated with Bacterial top IV x Bacterial DNA gyrase x GR
NCT06352541
/ Not yet recruitingPhase 1
Phase I Clinical Study, Evaluating Safety and Tolerability of PRO-232 an Ophthalmic Solution, Versus Placebo, When Applied to the Ocular Surface of Ophthalmologically and Clinically Healthy Volunteers.
CTR20240214
/ Active, not recruitingPhase 2
OT-601-C 治疗白内障手术术后眼部炎症的有效性和安全性的随机、盲法、阳性药物平行对照的多中心Ⅱ期临床研究
[Translation] A randomized, blinded, positive drug-controlled, multicenter phase II clinical study on the efficacy and safety of OT-601-C in the treatment of postoperative ocular inflammation after cataract surgery
CTR20230646
/ CompletedPhase 1
OT-601-C在中国健康受试者中单次、多次给药的药代动力学特征和安全性的Ⅰ期临床研究
[Translation] Phase I clinical study on the pharmacokinetic characteristics and safety of single and multiple doses of OT-601-C in healthy Chinese subjects
100 Clinical Results associated with Bacterial top IV x Bacterial DNA gyrase x GR
Login to view more data
100 Translational Medicine associated with Bacterial top IV x Bacterial DNA gyrase x GR
Login to view more data
0 Patents (Medical) associated with Bacterial top IV x Bacterial DNA gyrase x GR
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free